دانلود کتاب Longevity Industry 1.0 - Defining the Biggest and Most Complex Industry in Human History

فهرست مطالب :

Quotes and Advance Reviews 8 Preface by Margaretta Colangelo 11 Preface by Dmitry Kaminskiy 14 Facts vs. Fiction 19 PART I - Longevity Mega-Complexity: Challenges, Issues, Opportunities 25 1. The Biggest and Most Complex Industry in Human History 26 2. Formulating the Longevity Industry Framework 40 3. From BioTech Stagnation to Longevity: Forecasting on the Future of Longevity Biomedicine 56 4. Longevity Investing 1.0: Disproportions in the Current Longevity Investment Landscape 64 5. Longevity Investing 2.0: Why Traditional BioTech Analytics Fails Against the Longevity Industry’s Extreme Complexity 71 6. Longevity.Capital: Specialized Hybrid Investment Fund for Longevity Industry, De-Risking and Diversification 81 PART II - Longevity Policy and Governance 91 7. The Rise of Longevity Technocracies and MegaHubs: Governance and Policy as the Next Great Longevity Frontier (Contributor: Eric Kihlstrom) 92 8. Longevity Progressive and Regressive Nations: Israel, Singapore and the USA 118 9. The Swiss Longevity Valley: How Switzerland May Become a Global Longevity Financial Industry MegaHub by 2025 (Contributor: Stefan Hascoet) 131 10. The Longevity Leadership Role of the UK: The Emergence of Longevity-Focused Parliamentary Groups and Government Bodies (Contributor: Eric Kihlstrom) 148 11. California - Longevity Hype in Silicon Valley: Will the Traditional Approach to BioTech Investment Lead to a Longevity Boom, Bubble or Bust? (Contributor: Kate Batz) 166 12. The Future of Longevity Governance: How Longevity Will Become a Major Priority Item for the National Agendas of Progressive Countries by 2025 176 PART III - Longevity Financial Industry 178 13. The Longevity Financial Industry and Novel Financial System 179 14. Major Longevity Financial Industry Trends, Predictions and Insights 196 15. Longevity FinTech (Contributor: Sergey Balasanyan) 220 16. Longevity Finance and the Shift from FinTech 1.0 to FinTech 2.0 235 17. FinTech 2.0 and the Rise of Longevity Banks: Where Healthspan Meets Wealthspan 239 PART IV - Longevity Industry (Science, Technology & Biomedicine) 257 18. The Birth and Rise of Geroscience (The Science of Longevity) 258 19. Most Developed Domains of Longevity R&D and Top Longevity Scientists 264 20. The Current State of Longevity Clinical (Human) Trials 281 21. Precision Medicine and the Patient as CEO (Contributor: Robin Farmanfarmaian) 287 22. AI for Longevity and Precision Health (Contributor: Richard Siow) 299 23. Longevity FemTech (Contributor: Robin Farmanfarmaian) 309 24. Biomarkers of Longevity 2.0: The Shift Toward Actionable, AI-Empowered Biomarkers of Aging, Health and Longevity (Contributor: Franco Cortese) 316 25. The Crucial and Fundamental Role of AI in Longevity R&D and Practical Implementation 331 26. What if Geroscience Fails? - Pragmatic Optimism in the Longevity Industry and Defining Hype vs. Reality 346 Longevity Industry 2.0 Summary - DeepTech Engineering The Accelerated Trajectory of Human Longevity: The Blueprint and Pathway from 1.0 to 2.0 356 PART V - Longevity Industry Navigator 359 1. Longevity Industry in UK Landscape Overview 2018 360 2. Longevity Industry in Singapore Landscape Overview 2019 360 3. Longevity Industry in Israel Landscape Overview 2019 361 4. FemTech Healthcare Landscape Overview 2019 362 5. Longevity Industry in California Landscape Overview 2019 363 6. Top-100 Longevity Leaders 364 7. Top-100 Journalists Covering Advanced Biomedicine and Longevity 365 8. Top-50 Women Longevity Leaders 366 9. Top-30 Longevity Conferences 367 10. Advancing Financial Industry Longevity / AgeTech / WealthTech 368 11. Longevity Industry in Switzerland Landscape Overview 2019 369 12. Top-100 Supercentenarians Landscape Overview: 100 Longest-Lived, 100 Currently Living, 25 Socially and Professionally Active 370 13. 1000 Longevity Leaders IT-Platform 371 About Deep Knowledge Group 347 About the Authors 381 About the Contributors 383